HPV prevalence and risk factors in a population-based cervical cancer screening program in Tashkent, Uzbekistan
JNCI Cancer Spectrum · 16.11.2026
DOI: 10.1093/jncics/pkag121 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 16.11.2026. Verfasst von Nozimakhon Rakhmatullakhodjaevna Turabova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emerging Infectious Diseases, Research Institute of Virology, Tashkent, Uzbekistan. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Population-based evidence on high-risk human papillomavirus (hrHPV) and cervical screening outcomes in Uzbekistan is limited. We assessed hrHPV prevalence, district variation, associated factors, and cytological findings in Tashkent.
Methods
A cross-sectional study was conducted among 52,995 women aged 18–70 years attending routine cervical screening across Tashkent city during 2024–2025. HR-HPV testing was performed using real-time PCR; reflex liquid-based cytology was performed for all HPV-positive women. Multivariable logistic regression was used to identify independent determinants of HPV positivity (n = 52,995) and cytological abnormality (n = 2,255 HPV-positive women with adequate cytology).
Results
Overall HR-HPV positivity was 4.43% (95% CI: 4.26–4.61%), with significant heterogeneity across districts (p < 0.01); Bektemir district recorded the highest prevalence. Independent predictors of HPV positivity included older age (aOR 2.41, 95% CI 1.24–4.83, for 56–70 years), irregular menstruation (aOR 1.39, 95% CI 1.23–1.57), and early sexual debut, while barrier contraception (aOR 0.70, 95% CI 0.60–0.81) and grand multiparity (aOR 0.80, 95% CI 0.65–0.98) were protective. Among HPV-positive women, any cytological abnormality was detected in 24.6% and high-grade lesions in 17.3%. Keratosis was the strongest predictor of cytological abnormality (aOR 4.09–5.16, both p < 0.01).
Conclusions
This large population-based study establishes a comprehensive HPV epidemiological baseline for Tashkent and demonstrates the clinical yield of HPV-primary screening with reflexive cytology triage. District-level heterogeneity and identified risk profiles provide evidence for geographically targeted program optimization in support of Uzbekistan's progress toward WHO 90-70-90 cervical cancer elimination targets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emerging Infectious Diseases, Research Institute of Virology, Tashkent, Uzbekistan.
- Administration department, Research Institute of Virology, Tashkent, Uzbekistan.
- Department of Hepatology, Research Institute of Virology, Tashkent, Uzbekistan.
- Department of Biomedical Sciences, Pharmaceutical Technical University, Tashkent, Uzbekistan.
- Department of Microbiology and Antimicrobial Resistance, National Biopharmaceutical Research Institute, Tashkent, Uzbekistan.
Zitieren
APA
Turabova, N. R., Akhmedova, L. M., Akhmedova, S. K., Mirkasimova, K. K., Ruzmetova, S. I., Kucharova, Z. A., Tuychiev, L. N., Musabaev, E. I., Ibadullaeva, N. S., Sultonqulova, S. Z., Shodieva, F. S. K., & Mirzaev, U. K. (2026). HPV prevalence and risk factors in a population-based cervical cancer screening program in Tashkent, Uzbekistan. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkag121
Vancouver
Turabova NR, Akhmedova LM, Akhmedova SK, Mirkasimova KK, Ruzmetova SI, Kucharova ZA, et al. HPV prevalence and risk factors in a population-based cervical cancer screening program in Tashkent, Uzbekistan. JNCI Cancer Spectrum. 2026. doi:10.1093/jncics/pkag121
BibTeX
@article{Turabova2026,
author = {Turabova, Nozimakhon Rakhmatullakhodjaevna and Akhmedova, Lyubov Mikhaylovna and Akhmedova, Shakhnoza Khayrullaevna and Mirkasimova, Kholida Khafizovna and Ruzmetova, Sohiba Islomboevna and Kucharova, Zarina Alisherovna and Tuychiev, Laziz Nadyrovich and Musabaev, Erkin Isakovich and Ibadullaeva, Nargiz Sapievna and Sultonqulova, Sarvinoz Zohidjonovna and Shodieva, Fatima Shokir Kizi and Mirzaev, Ulugbek Khudayberdievich},
title = {HPV prevalence and risk factors in a population-based cervical cancer screening program in Tashkent, Uzbekistan},
journal = {JNCI Cancer Spectrum},
year = {2026},
doi = {10.1093/jncics/pkag121}
}
EUVIMED